Trial · NCT01954927
Results by group20
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 20
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Successful Pain Interventions by Arm Between Presentation and 3 Hours Post Administration of Study Drug | Gabapentin | No | 13 | Participants | |
| Number of Participants With Successful Pain Interventions by Arm Between Presentation and 3 Hours Post Administration of Study Drug | Placebo | No | 17 | Participants | |
| Number of Participants With Successful Pain Interventions by Arm Between Presentation and 3 Hours Post Administration of Study Drug | Gabapentin | Yes | 27 | Participants | |
| Number of Participants With Successful Pain Interventions by Arm Between Presentation and 3 Hours Post Administration of Study Drug | Placebo | Yes | 25 | Participants | |
| Morphine Equivalent Doses Administered From Presentation to 3-hours Post Treatment With Gabapentin/Placebo | Gabapentin | 0.12 | Inter-Quartile Range 0.09 to 0.22 | mg/kg | |
| Morphine Equivalent Doses Administered From Presentation to 3-hours Post Treatment With Gabapentin/Placebo | Placebo | 0.13 | Inter-Quartile Range 0.09 to 0.22 | mg/kg | |
| Number of Participants With Successful Pain Interventions by Arm Between Presentation and Point of Decision for Either Hospital Admission or Discharge to Home | Gabapentin | No | 10 | Participants | |
| Number of Participants With Successful Pain Interventions by Arm Between Presentation and Point of Decision for Either Hospital Admission or Discharge to Home | Placebo | No | 17 | Participants | |
| Number of Participants With Successful Pain Interventions by Arm Between Presentation and Point of Decision for Either Hospital Admission or Discharge to Home | Gabapentin | Yes | 30 | Participants | |
| Number of Participants With Successful Pain Interventions by Arm Between Presentation and Point of Decision for Either Hospital Admission or Discharge to Home | Placebo | Yes | 27 | Participants | |
| Morphine Equivalent Doses Administered From Presentation to the Point of Decision for Either Admission or Discharge to Home | Gabapentin | 0.13 | Inter-Quartile Range 0.10 to 0.25 | mg/kg | |
| Morphine Equivalent Doses Administered From Presentation to the Point of Decision for Either Admission or Discharge to Home | Placebo | 0.13 | Inter-Quartile Range 0.09 to 0.25 | mg/kg | |
| Hospital Admission | Gabapentin | No | 32 | Participants | |
| Hospital Admission | Placebo | No | 32 | Participants | |
| Hospital Admission | Gabapentin | Yes | 10 | Participants | |
| Hospital Admission | Placebo | Yes | 12 | Participants | |
| Absolute Change in Pain From Study Drug to 3 Hours Post Administration of Study Drug | Gabapentin | 0 | Inter-Quartile Range 0 to 2 | score on a scale | |
| Absolute Change in Pain From Study Drug to 3 Hours Post Administration of Study Drug | Placebo | 0.5 | Inter-Quartile Range 0 to 2 | score on a scale | |
| Absolute Change in Pain, Study Drug to Hospital Discharge Decision | Gabapentin | 1.0 | Inter-Quartile Range 0.0 to 3.0 | score on a scale | |
| Absolute Change in Pain, Study Drug to Hospital Discharge Decision | Placebo | 0.5 | Inter-Quartile Range 0.0 to 2.0 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01954927/results